Nanotech Insights #10
Nanotech Insights #10
Dear Small & Advanced Technology Investor,
“When you get $12 for soybeans and $6 for corn and you see that steel and oil are soaring . . . yes, there is a lot of potential inflation down the road” . . . . further, commenting on GDP growth of anything under 1%/year when population growth is about 1%/year . . . “Yeah, I think we are in a recession.”
Warren Buffett – CNBC Interview:
We concur.
That’s why the next 2-3 years will be so exciting for establishing long-term investment positions and joining with great scientific, technical and executive teams to build profitable corporate outcomes.
This is probably our last Nanotech Insights. They began in October of 2007 and were meant to explore the state of early 2008 nanotech investing. You can find them archived on BlogNano’s “previous posts” at http://www.nanotechnology.com/blogs/blognano/index.html. The buying opportunity period we have been talking about for nearly 5 years is upon us. Writing these Insights has been enjoyable, but we have to focus our efforts and attention on serving our corporate finance and investor clients, now.
Now, let’s orient via the overall stock market: We remain nervous bulls, but expect the market to top before June 10 (the Dow 30 remains the strongest index) and possibly before the end of next week. From there, we look for a continuation of the bear market to important lows sometime between September 2008 and December 2009.
Our records show the last half position of BNT was sold at $15.29 for a substantial, short-term profit.
TINY strengthened as we predicted. We would cancel our unfilled orders in TGAL and NVAX.
We were wrong on NVEC, which rallied to 32, while SMMX, KEI, SRDX, BPAX and FLML all performed as expected. We have no opinion on these now.
The “nimble” among you would have bought NGEN at $0.43 (we would carry a stop loss at 0.35 and raise that 1 cent/day until stopped out). You would have bought CHRT at $5.58 (we would carry a stop loss at $5.40 and raise it 2 cents/day until stopped out). You would have bought KOPN at $2.64 (we would carry a protective stop at 2.69 and raise it 3 cents/day until stopped out).
Obviously, we are not so excited by the illiquid stocks in the paragraph above, and given our views on the stock market, this seems a logical, lowered risk, way to exit.
Specific instructions were given for the semiconductor stocks below, and you can see what we believe to be superior results for yourself.
I hope that you made the profits!
TSRA – We would have bought it at $20 and sold for a loss at $19.24.
FORM – We would have bought it at $19.10 and sold for a small loss at $18.64.
ADI – We would have bought it at $29.75 and would carry with a protective stop at $31.39 and raise the stop 10 cents/day until stopped out for a good profit.
MTSC – We would have bought it at $31.01 and would carry a protective stop at 33.64 and raise the stop 10 cents/day until stopped out for another good profit.
CCMP – We would have bought at $31.87 and would carry a protective stop at $33.09 and raise the stop 10 cents/day until stopped out for another good one.
ALTR – We would have bought at $18.10 and would carry a protective stop at 20.88 and raise the stop 10 cents/day until stopped out for a great profit.
XLNX – We would have bought it at $23.11 and sold it for a tiny loss at $22.89.
Wow . . 3 small losers vs. 4 giant winners . . . Our public record of success since March 2006 continues, and we are very happy with our proprietary stock trading technology (especially when informed by our in-house, scientific, technical and engineering expertise).
The time has come to close this series of communications with our closest subscribers. While you Insights readers are a small and rather special, self-selected group within our more than 25,000 Nanotechnology.com subscribers, the time for action has come. Our team’s thoughts about the markets, business model, investment philosophy and basic premises are well known. We must now focus on our clientele. Investments must be thoroughly scrutinized and made; extensive scientific, technical and business due-diligence must be performed, board direction, deep consultation and business advisory services provided. Capital must be raised. Our corporate and individual clients deserve The Nanotech Company, LLC and its Scientific Advisory Board’s first and best, undistracted advice.
Again: This is probably our last Nanotech Insights. They began in October of 2007 and were meant to explore the state of early 2008 nanotech investing. You can find them archived on BlogNano’s “previous posts” at http://www.nanotechnology.com/blogs/blognano/index.html. The buying opportunity period we have been talking about for nearly 5 years is upon us. Writing these Insights has been enjoyable, but we have to focus our efforts and attention on serving our corporate finance and investor clients, now.
Best regards and wishes of success, health and prosperity for you and yours,
Darrell Brookstein
Disclosures and Disclaimers
GENERAL TERMS*
No investment opinion or other advice is being rendered on any stock or company. All of the trading stocks we recommend should be considered highly speculative; you can lose some or all of your money. It should be assumed that the Author and editor and their associates may hold or dispose of or trade in positions in any securities mentioned at any time. No fee in cash, shares or options was paid for this report. Please be responsible for understanding the terms and vocabulary of stock market investing. Here is an unaffiliated glossary site that may be useful:
http://www.traders.com/Documentation/RESource_docs/Glossary/glossary.html
Disclaimer
The Nanotech Company, LLC, Darrell Brookstein and/or Resource Development, Inc. are not registered investment advisors nor broker/dealers. Readers are advised that the material contained herein should be used solely for informational purposes. The
Author does not purport to tell, or suggest to, readers which investment securities they should buy or sell for themselves. Readers should always conduct their own research and due diligence and obtain professional advice before making any investment decision. The Author will not be liable for any loss or damage caused by a reader's reliance on information obtained in any of our newsletters, special reports or on our web site or sent by email or mail. Our readers are solely responsible for their own investment decisions. The information contained herein does not constitute a representation by the publisher or a solicitation for the purchase or sale of securities. Our opinions and analyses are based on sources believed to be reliable and are written in good faith, but no representation or warranty, expressed or implied, is made as to their accuracy or completeness. All information contained in our newsletters or on our web site should be independently verified with the companies mentioned. The editor and publisher are not responsible for typographical or other errors or omissions. There is no guarantee of investment results herein whatsoever, either explicit or implied. Past results are no guarantee of future results or even profitability. Investors are cautioned that they may lose all or a portion of their investment if they make a purchase or short sale in these speculative stocks.
<< Home